Products - Spinal conditions | Topic | NICE

Showing 3 products

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

Intrathecal onasemnogene abeparvovec for treating spinal muscular atrophy in people 2 years and over [ID6556]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
26 August 2026
Neuro-Cells stem-cell treatment for traumatic spinal cord injury [ID6588]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Filgotinib for treating axial spondyloarthritis [ID6594]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC